2023 Q2 Form 10-K Financial Statement

#000147793223003007 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue $262.0K $152.0K $2.612M
YoY Change 2.75% -93.87% 5.28%
Cost Of Revenue $52.00K -$6.000K $1.540M
YoY Change 246.67% -102.6% 566.67%
Gross Profit $210.0K $158.0K $1.072M
YoY Change -12.5% -92.98% -52.36%
Gross Profit Margin 80.15% 103.95% 41.04%
Selling, General & Admin $1.230M $1.582M $3.935M
YoY Change 12.53% -62.18% -5.93%
% of Gross Profit 585.71% 1001.27% 367.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $59.00K $178.0K $178.0K
YoY Change 18.0% 439.39% 85.42%
% of Gross Profit 28.1% 112.66% 16.6%
Operating Expenses $2.005M $1.620M $8.479M
YoY Change 3.03% -62.14% 98.15%
Operating Profit -$1.795M -$1.462M -$7.407M
YoY Change 5.22% -27.94% 265.06%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$17.00K -$17.00K -$2.511M
YoY Change -89.38% -100.33% 8.37%
Pretax Income -$1.812M -$2.933M -$9.918M
YoY Change -2.89% -193.05% -414.66%
Income Tax $7.000K $1.125M -$474.0K
% Of Pretax Income
Net Earnings -$1.819M -$4.058M -$9.444M
YoY Change 25.1% -275.14% -507.6%
Net Earnings / Revenue -694.27% -2669.74% -361.56%
Basic Earnings Per Share -$0.18 -$1.00
Diluted Earnings Per Share -$0.18 -$0.41 -$1.00
COMMON SHARES
Basic Shares Outstanding 9.923M shares 9.426M shares
Diluted Shares Outstanding 9.923B shares 9.426M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.000K $824.0K $824.0K
YoY Change -99.65% -22.41% -22.41%
Cash & Equivalents $6.000K $824.0K
Short-Term Investments
Other Short-Term Assets $173.0K $127.0K $2.794M
YoY Change 226.42% 252.78% -54.24%
Inventory $74.00K $64.00K $64.00K
Prepaid Expenses $2.541M $2.663M
Receivables $66.00K $89.00K $89.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.864M $3.771M $3.771M
YoY Change -62.68% -47.91% -47.91%
LONG-TERM ASSETS
Property, Plant & Equipment $654.0K $660.0K $660.0K
YoY Change -32.65% -34.07% -34.07%
Goodwill $16.50M $16.50M
YoY Change -7.4% -7.4%
Intangibles $4.270M
YoY Change
Long-Term Investments
YoY Change
Other Assets $463.0K $463.0K $463.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $22.06M $21.90M $21.90M
YoY Change -2.71% -2.27% -2.27%
TOTAL ASSETS
Total Short-Term Assets $2.864M $3.771M $3.771M
Total Long-Term Assets $22.06M $21.90M $21.90M
Total Assets $24.92M $25.67M $25.67M
YoY Change -17.88% -13.42% -13.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.651M $1.305M $1.305M
YoY Change 972.08% 747.4% 747.4%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $479.0K $474.0K $474.0K
YoY Change 69.86% 68.09% 68.09%
Total Short-Term Liabilities $2.412M $2.071M $2.071M
YoY Change 41.22% 57.85% 57.85%
LONG-TERM LIABILITIES
Long-Term Debt $40.00K $47.00K $47.00K
YoY Change -84.79% -82.66% -82.66%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $40.00K $47.00K $47.00K
YoY Change -91.42% -94.71% -82.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.412M $2.071M $2.071M
Total Long-Term Liabilities $40.00K $47.00K $47.00K
Total Liabilities $2.452M $2.118M $2.118M
YoY Change 12.79% -3.73% -3.73%
SHAREHOLDERS EQUITY
Retained Earnings -$62.35M -$60.54M
YoY Change 18.67% 18.48%
Common Stock $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.691M $1.691M
YoY Change 5.75%
Treasury Stock Shares
Shareholders Equity $22.47M $23.55M $23.55M
YoY Change
Total Liabilities & Shareholders Equity $24.92M $25.67M $25.67M
YoY Change -17.88% -13.42% -13.42%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$1.819M -$4.058M -$9.444M
YoY Change 25.1% -275.14% -507.6%
Depreciation, Depletion And Amortization $59.00K $178.0K $178.0K
YoY Change 18.0% 439.39% 85.42%
Cash From Operating Activities -$688.0K -$2.793M -$2.793M
YoY Change 28.36% -276.77% 539.13%
INVESTING ACTIVITIES
Capital Expenditures $222.0K $1.221M $1.221M
YoY Change -169.59% -190.51% -182.17%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $758.0K $758.0K
YoY Change -207.06% -72.28%
Cash From Investing Activities -$222.0K -$463.0K -$463.0K
YoY Change -30.41% -77.49% -137.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $92.00K 3.018M $3.018M
YoY Change -93.83% -43214.29% 1102.39%
NET CHANGE
Cash From Operating Activities -$688.0K -2.793M -$2.793M
Cash From Investing Activities -$222.0K -463.0K -$463.0K
Cash From Financing Activities $92.00K 3.018M $3.018M
Net Change In Cash -$818.0K -238.0K -$238.0K
YoY Change -228.41% -50.83% -122.41%
FREE CASH FLOW
Cash From Operating Activities -$688.0K -$2.793M -$2.793M
Capital Expenditures $222.0K $1.221M $1.221M
Free Cash Flow -$910.0K -$4.014M -$4.014M
YoY Change 319.35% -237.04% -482.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25668000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1691000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85975000 usd
CY2023Q1 ebi Current Cryptocurrencies Net
CurrentCryptocurrenciesNet
4000 usd
CY2023Q1 ebi Receivable From Stockholder
ReceivableFromStockholder
-200000 usd
CY2022Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
282000 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001730869
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2023 ebi Warrants Outstanding Shares Beginning
WarrantsOutstandingSharesBeginning
4991000 shares
CY2023 ebi Warrants Outstanding Weighted Average Conversion Price Beginning
WarrantsOutstandingWeightedAverageConversionPriceBeginning
2.83
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 pure
CY2022 ebi Non Deductible Stock Compensation Rate
NonDeductibleStockCompensationRate
0 pure
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023 dei Entity File Number
EntityFileNumber
000-56142
CY2023 dei Entity Registrant Name
EntityRegistrantName
Everything Blockchain, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q1 ebi Reserve For Legal Settlements
ReserveForLegalSettlements
154000 usd
CY2022Q1 ebi Reserve For Legal Settlements
ReserveForLegalSettlements
154000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
279000 usd
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
108000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2071000 usd
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1091922
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
12574 Flagler Center Blvd
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 101
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Jacksonville
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32258
CY2023 dei City Area Code
CityAreaCode
904
CY2023 dei Local Phone Number
LocalPhoneNumber
454-2111
CY2023 dei Security12g Title
Security12gTitle
Common Stock
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
6900000 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9923304 shares
CY2023 dei Auditor Firm
AuditorFirmId
681600001
CY2023 dei Auditor Name
AuditorName
Elkana Amitai CPA
CY2023 dei Auditor Location
AuditorLocation
Mitzpe Netofa, Israel
CY2022Q1 us-gaap Cash
Cash
1062000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
89000 usd
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
11000 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
60000 usd
CY2022Q1 ebi Current Cryptocurrencies Net
CurrentCryptocurrenciesNet
3152000 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2918000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
127000 usd
CY2022Q1 us-gaap Other Assets
OtherAssets
36000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
7239000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
17823000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
4270000 usd
CY2022Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3119000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
463000 usd
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
463000 usd
CY2023Q1 us-gaap Assets
Assets
25668000 usd
CY2022Q1 us-gaap Assets
Assets
29645000 usd
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
744000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
13000 usd
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
24000 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
474000 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1312000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
47000 usd
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
271000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
617000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
47000 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
888000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2118000 usd
CY2022Q1 us-gaap Liabilities
Liabilities
2200000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9923304 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8604038 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1599000 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
80134000 usd
CY2022Q1 ebi Receivable From Stockholder
ReceivableFromStockholder
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60535000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51091000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23550000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27445000 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29645000 usd
CY2023 us-gaap Revenues
Revenues
2612000 usd
CY2022 us-gaap Revenues
Revenues
2481000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
1540000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
231000 usd
CY2023 us-gaap Gross Profit
GrossProfit
1072000 usd
CY2022 us-gaap Gross Profit
GrossProfit
2250000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3935000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2208000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2912000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1975000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
178000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1319000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
135000 usd
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
8479000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
4279000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7407000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2029000 usd
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2511000 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5181000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9918000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3152000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-474000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
835000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-9444000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9425769 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7460213 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9425769 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9792915 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1539000 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
669000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1109000 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
19623000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1647000 usd
CY2022 ebi Warrant Exercise Amount
WarrantExerciseAmount
140000 usd
CY2022 ebi Issuance Of Series A Preferred For Services Amount
IssuanceOfSeriesAPreferredForServicesAmount
2000000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-1599000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2317000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27445000 usd
CY2023 ebi Issuance Of Series C Preferred Amount
IssuanceOfSeriesCPreferredAmount
2500000 usd
CY2023 ebi Warrant Exercise Amount
WarrantExerciseAmount
585000 usd
CY2023 ebi Proceeds From Sale Of Productive Assets Amount
ProceedsFromSaleOfProductiveAssetsAmount
-92000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
2556000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-9444000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23550000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-9444000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2317000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2912000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1975000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1319000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
135000 usd
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-618000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
617000 usd
CY2023 ebi Reversal Of Bad Debt
ReversalOfBadDebt
0 usd
CY2022 ebi Reversal Of Bad Debt
ReversalOfBadDebt
233000 usd
CY2023 ebi Net Loss On Exchanges
NetLossOnExchanges
-4000 usd
CY2022 ebi Net Loss On Exchanges
NetLossOnExchanges
0 usd
CY2023 ebi Realizednetgainlossoninvestmentincryptocurrency
Realizednetgainlossoninvestmentincryptocurrency
-186000 usd
CY2022 ebi Realizednetgainlossoninvestmentincryptocurrency
Realizednetgainlossoninvestmentincryptocurrency
1180000 usd
CY2023 ebi Loss On Cryptocurrency Impairment
LossOnCryptocurrencyImpairment
0 usd
CY2022 ebi Loss On Cryptocurrency Impairment
LossOnCryptocurrencyImpairment
-16000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2206000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3777000 usd
CY2023 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
178000 usd
CY2022 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
96000 usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
78000 usd
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-22000 usd
CY2023 ebi Increase Decrease In Interest Receivable
IncreaseDecreaseInInterestReceivable
0 usd
CY2022 ebi Increase Decrease In Interest Receivable
IncreaseDecreaseInInterestReceivable
-32000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
60000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
101000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
136000 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
91000 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
499000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-10000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
11000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
442000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
561000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
171000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-135000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2793000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-437000 usd
CY2023 ebi Acquisition Of Cryptocurrencies Net
AcquisitionOfCryptocurrenciesNet
0 usd
CY2022 ebi Acquisition Of Cryptocurrencies Net
AcquisitionOfCryptocurrenciesNet
-3084000 usd
CY2023 ebi Proceeds From Sale Of Cryptocurrencies
ProceedsFromSaleOfCryptocurrencies
755000 usd
CY2022 ebi Proceeds From Sale Of Cryptocurrencies
ProceedsFromSaleOfCryptocurrencies
5756000 usd
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1221000 usd
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1486000 usd
CY2023 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3000 usd
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
85000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
23000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-463000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1248000 usd
CY2023 ebi Payment To Related Party
PaymentToRelatedParty
0 usd
CY2022 ebi Payment To Related Party
PaymentToRelatedParty
-500000 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
32000 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
18000 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2500000 usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
550000 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
769000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3018000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
251000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-238000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1062000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1062000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
824000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1062000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
58000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
35000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
3000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 ebi Conversion Of Accounts Payable To Related Party To Common Stock
ConversionOfAccountsPayableToRelatedPartyToCommonStock
35000 usd
CY2022 ebi Conversion Of Accounts Payable To Related Party To Common Stock
ConversionOfAccountsPayableToRelatedPartyToCommonStock
40000 usd
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
92000 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
CY2023 ebi Exercise Of Warrant For Receivable
ExerciseOfWarrantForReceivable
200000 usd
CY2022 ebi Exercise Of Warrant For Receivable
ExerciseOfWarrantForReceivable
0 usd
CY2023 ebi Loan Of Cryptocurrency
LoanOfCryptocurrency
0 usd
CY2022 ebi Loan Of Cryptocurrency
LoanOfCryptocurrency
500000 usd
CY2023 ebi Currency Received For Payment Under Contract
CurrencyReceivedForPaymentUnderContract
0 usd
CY2022 ebi Currency Received For Payment Under Contract
CurrencyReceivedForPaymentUnderContract
240000 usd
CY2023 ebi Fair Value Of Assets In Acquisitions
FairValueOfAssetsInAcquisitions
0 usd
CY2022 ebi Fair Value Of Assets In Acquisitions
FairValueOfAssetsInAcquisitions
20414000 usd
CY2023 ebi Fair Value Of Liabilities Assumed In Acquisitions
FairValueOfLiabilitiesAssumedInAcquisitions
0 usd
CY2022 ebi Fair Value Of Liabilities Assumed In Acquisitions
FairValueOfLiabilitiesAssumedInAcquisitions
791000 usd
CY2023 ebi Accounts Receivable Settlement For Render Payment
AccountsReceivableSettlementForRenderPayment
0 usd
CY2022 ebi Accounts Receivable Settlement For Render Payment
AccountsReceivableSettlementForRenderPayment
233000 usd
CY2023 ebi Conversion Of Note Receivable In Exchange For Common Stock And Preferred Stock
ConversionOfNoteReceivableInExchangeForCommonStockAndPreferredStock
0 usd
CY2022 ebi Conversion Of Note Receivable In Exchange For Common Stock And Preferred Stock
ConversionOfNoteReceivableInExchangeForCommonStockAndPreferredStock
1599000 usd
CY2023 ebi Issuance Of Stock For Services Non Cash
IssuanceOfStockForServicesNonCash
0 usd
CY2022 ebi Issuance Of Stock For Services Non Cash
IssuanceOfStockForServicesNonCash
1110000 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2000000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The most significant estimates and judgments relate to revenue recognition; sales returns and other allowances; allowance for doubtful accounts; valuation of inventory; valuation of long-lived assets and finite-lived intangible assets; recoverability of goodwill; acquisition method of accounting; contingencies; and income taxes. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On a regular basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p>
CY2023 us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
1174000 usd
CY2022 us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
303000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments which potentially subject the Company to a concentration of credit risk consist principally of temporary cash investments and accounts receivable. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Concentrations of credit risk with respect to trade receivables and commodities are limited due to the Company’s diverse group of customers. The Company establishes an allowance for doubtful accounts when events and circumstances regarding the collectability of its receivables or the selling of its commodities warrant based upon factors such as the credit risk of specific customers, historical trends, other information, and past bad debt history. The outstanding balances are stated net of an allowance for doubtful accounts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenues from one customer represent $1.0 million of the Company’s revenue for the year ended January 31, 2022.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company may occasionally maintain amounts on deposit with a financial institution that are in excess of the federally insured limit of $250,000. The risk is managed by maintaining all deposits in high-quality financial institutions. The Company had $0.4 million and $0.1 million in excess of federally insured limits on January 31, 2023, and January 31, 2022, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our cryptocurrency balances are maintained in accounts held by institutions located in and outside the United States. The Company maintains amounts on deposit that often exceed coverage from third party insured limit of up to $1,000,000. The risk is managed by maintaining multiple accounts with various accounts held in a cold storage wallet. The Company had $4,000 in excess of amounts protected by insurance.</p>
CY2023Q1 ebi Federally Insured Limit
FederallyInsuredLimit
250000 usd
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
400000 usd
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
100000 usd
CY2023Q1 us-gaap Deposits
Deposits
1000000 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
4000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
700000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4333000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
63000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4270000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3142000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3119000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
100000 usd
CY2022Q3 ebi Bitcoins Sold
BitcoinsSold
7000000 usd
CY2022Q3 ebi Hex Tokens Aggregate Amount
HexTokensAggregateAmount
304747 usd
CY2023 ebi Schedule Of Cryptocurrency Assets
ScheduleOfCryptocurrencyAssets
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="9" style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Current Assets </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As of January 31, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Coin Symbol</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FMV </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">BTC </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">272</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">ETH </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">HEX </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,879</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,152</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1 ebi Fair Market Value
FairMarketValue
4000 usd
CY2022Q1 ebi Fair Market Value
FairMarketValue
3152000 usd
CY2023 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
2200000 usd
CY2023 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
200000 usd
CY2022 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3800000 usd
CY2022 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
1200000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
835000 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1061000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
175000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
660000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
16504000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
17823000 usd
CY2023 us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
500000 usd
CY2022 us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
600000 usd
CY2023Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.063 pure
CY2022Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.062 pure
CY2023 ebi Debt Maturity Range
DebtMaturityRange
from 2023 through 2026
CY2021Q4 ebi Hex Tokens Aggregate Amount
HexTokensAggregateAmount
1000000.0 usd
CY2021Q4 ebi Hex Tokens Sold
HexTokensSold
5000000 usd
CY2021Q4 ebi Hex Tokens Per Share
HexTokensPerShare
0.20
CY2022Q3 ebi Hex Tokens Sold
HexTokensSold
10000000 usd
CY2022Q3 ebi Hex Tokens Aggregate Amount
HexTokensAggregateAmount
450000 usd
CY2022Q3 ebi Loss On Sale Of Hex Tokens
LossOnSaleOfHexTokens
47000 usd
CY2022Q3 ebi Hex Tokens Sold
HexTokensSold
6700000 usd
CY2022Q3 ebi Loss On Sale Of Hex Tokens
LossOnSaleOfHexTokens
195000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8604038 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9923304 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8604038 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500000 shares
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
250000 usd
CY2022Q4 ebi Common Stock Resulting In The Company Receivable
CommonStockResultingInTheCompanyReceivable
200000 usd
CY2022Q2 ebi Preferred Stock Sold Shares
PreferredStockSoldShares
250000 shares
CY2022Q2 ebi Preferred Stock Sold Value
PreferredStockSoldValue
1000000.0 usd
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
250000 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
560928 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500000 shares
CY2022Q2 us-gaap Cash
Cash
500000 usd
CY2023 ebi Schedule Of Warrant Activity
ScheduleOfWarrantActivity
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Conversion</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants outstanding at January 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,675,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cancelled/Expired </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(350,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(190,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.32</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,856,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.54</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants outstanding at January 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,991,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.83</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cancelled/Expired </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(875,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.71</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(785,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">25,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants outstanding at January 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,356,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.60</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022 ebi Warrants Outstanding Shares Beginning
WarrantsOutstandingSharesBeginning
2675000 shares
CY2022 ebi Warrants Outstanding Weighted Average Conversion Price Beginning
WarrantsOutstandingWeightedAverageConversionPriceBeginning
1.00
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
350000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.58
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
190000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
1.32
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
2856000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.54
CY2022 ebi Warrants Outstanding Shares Ending
WarrantsOutstandingSharesEnding
4991000 shares
CY2022 ebi Warrants Outstanding Weighted Average Conversion Price Ending
WarrantsOutstandingWeightedAverageConversionPriceEnding
2.83
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
875000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.71
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
785000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
1.00
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
25000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.00
CY2023 ebi Warrants Outstanding Shares Ending
WarrantsOutstandingSharesEnding
3356000 shares
CY2023 ebi Warrants Outstanding Weighted Average Conversion Price Ending
WarrantsOutstandingWeightedAverageConversionPriceEnding
3.60
CY2023Q1 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
250000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26662 shares
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
406000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
97000 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
116000 usd
CY2023Q1 ebi Deferred Tax Liabilities Crypto Fair Value Adjustments
DeferredTaxLiabilitiesCryptoFairValueAdjustments
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9918000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3152000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
112000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
362000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
32000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
77000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
144000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
439000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-510000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
327000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-108000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
69000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-618000 usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
396000 usd
CY2023 ebi Income Tax Expense Benefit Provision
IncomeTaxExpenseBenefitProvision
-474000 usd
CY2022 ebi Income Tax Expense Benefit Provision
IncomeTaxExpenseBenefitProvision
835000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
700000 usd
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1069000 usd
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
406000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
11000 usd
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1780000 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
406000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1452000 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
328000 usd
CY2022Q1 ebi Deferred Tax Liabilities Crypto Fair Value Adjustments
DeferredTaxLiabilitiesCryptoFairValueAdjustments
-536000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
231000 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
371000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
328000 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1023000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
617000 usd
CY2023Q1 ebi Valuation Allowance Deferred Tax Asset Change In Amount1
ValuationAllowanceDeferredTaxAssetChangeInAmount1
1452000 usd
CY2022Q1 ebi Valuation Allowance Deferred Tax Asset Change In Amount1
ValuationAllowanceDeferredTaxAssetChangeInAmount1
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9918000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3152000 usd
CY2023 ebi Effective Income Tax Amount Reconciliation At Statutory Income Tax Amount
EffectiveIncomeTaxAmountReconciliationAtStatutoryIncomeTaxAmount
-2083000 usd
CY2023 ebi Effective Income Tax Rate Reconciliation At Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtStatutoryIncomeTaxRate
0.2100 pure
CY2022 ebi Effective Income Tax Amount Reconciliation At Statutory Income Tax Amount
EffectiveIncomeTaxAmountReconciliationAtStatutoryIncomeTaxAmount
662000 usd
CY2022 ebi Effective Income Tax Rate Reconciliation At Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtStatutoryIncomeTaxRate
0.2100 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Beat Amount
EffectiveIncomeTaxRateReconciliationBeatAmount
-339000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.0340 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Beat Amount
EffectiveIncomeTaxRateReconciliationBeatAmount
116000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.0368 pure
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1452000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1460 pure
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2023 ebi Non Deductible Stock Compensationamount
NonDeductibleStockCompensationamount
75000 usd
CY2023 ebi Non Deductible Stock Compensation Rate
NonDeductibleStockCompensationRate
-0.0080 pure
CY2022 ebi Non Deductible Stock Compensationamount
NonDeductibleStockCompensationamount
0 usd
CY2023 ebi Effective Income Tax Amount Reconciliation Permanent Differences
EffectiveIncomeTaxAmountReconciliationPermanentDifferences
277000 usd
CY2023 ebi Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0280 pure
CY2022 ebi Effective Income Tax Amount Reconciliation Permanent Differences
EffectiveIncomeTaxAmountReconciliationPermanentDifferences
69000 usd
CY2022 ebi Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.0219 pure
CY2023 ebi Effective Income Tax Amount Reconciliation Return To Provision True Up
EffectiveIncomeTaxAmountReconciliationReturnToProvisionTrueUp
144000 usd
CY2023 ebi Effectiveincometaxratereconciliationreturn To Provision True Up
EffectiveincometaxratereconciliationreturnToProvisionTrueUp
0.0150 pure
CY2022 ebi Effective Income Tax Amount Reconciliation Return To Provision True Up
EffectiveIncomeTaxAmountReconciliationReturnToProvisionTrueUp
-12000 usd
CY2022 ebi Effectiveincometaxratereconciliationreturn To Provision True Up
EffectiveincometaxratereconciliationreturnToProvisionTrueUp
-0.0038 pure
CY2023 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
-474000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0470 pure
CY2022 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
835000 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2649 pure
CY2023 ebi Total Federal Nol
TotalFederalNol
2751000 usd
CY2023 ebi Total State Nol Gross
TotalStateNolGross
2682000 usd
CY2023 ebi Total State Nol Tax Effected
TotalStateNolTaxEffected
122000 usd
CY2023 ebi Net Operating Loss Summary By Jurisdiction Gross
NetOperatingLossSummaryByJurisdictionGross
5433000 usd
CY2023 ebi Total Net Operating Loss Of Federal And State Tax Effected
TotalNetOperatingLossOfFederalAndStateTaxEffected
700000 usd
CY2023 ebi Total Federal Nol Tax Effected
TotalFederalNolTaxEffected
578000 usd
CY2023 ebi Total Net Operating Loss Of Federal And State Gross
TotalNetOperatingLossOfFederalAndStateGross
5433000 usd
CY2023 ebi Net Operating Loss Summary By Jurisdiction Tax Effected
NetOperatingLossSummaryByJurisdictionTaxEffected
700000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-9444000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2317000 usd
CY2023 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
9426 shares
CY2022 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
7460 shares
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2333 shares
CY2023 ebi Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9426 shares
CY2022 ebi Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9793 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24

Files In Submission

Name View Source Status
ebi-20230131_pre.xml Edgar Link unprocessable
0001477932-23-003007-index-headers.html Edgar Link pending
0001477932-23-003007-index.html Edgar Link pending
0001477932-23-003007.txt Edgar Link pending
0001477932-23-003007-xbrl.zip Edgar Link pending
ebi-20230131.xsd Edgar Link pending
ebi-20230131_cal.xml Edgar Link unprocessable
ebi-20230131_def.xml Edgar Link unprocessable
ebi_10k.htm Edgar Link pending
ebi_ex311.htm Edgar Link pending
ebi_ex312.htm Edgar Link pending
ebi_ex321.htm Edgar Link pending
ebi_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
ebi-20230131_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ebi_10k_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending